CCI
BMRN icon

Columbus Circle Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Columbus Circle Investors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-84,232
Closed -$7.84M – 185
2017
Q3 		$7.84M Sell
84,232
-16,548
-16% -$1.46M 0.13% 149
2017
Q2 		$9.15M Sell
100,780
-157,202
-61% -$14.3M 0.15% 131
2017
Q1 		$22.6M Sell
257,982
-50,108
-16% -$4.46M 0.32% 90
2016
Q4 		$25.5M Buy
308,090
+39,497
+15% +$3.4M 0.33% 82
2016
Q3 		$24.9M Buy
268,593
+90,238
+51% +$8.5M 0.27% 86
2016
Q2 		$13.9M Sell
178,355
-43,303
-20% -$3.68M 0.14% 143
2016
Q1 		$18.3M Sell
221,658
-42,341
-16% -$3.44M 0.16% 128
2015
Q4 		$27.7M Buy
263,999
+37,615
+17% +$3.93M 0.22% 104
2015
Q3 		$23.8M Buy
226,384
+10,384
+5% +$1.39M 0.2% 113
2015
Q2 		$29.5M Sell
216,000
-138,487
-39% -$17.2M 0.21% 119
2015
Q1 		$44.2M Sell
354,487
-96,327
-21% -$10.2M 0.3% 87
2014
Q4 		$40.8M Sell
450,814
-219,490
-33% -$18.3M 0.29% 85
2014
Q3 		$48.4M Sell
670,304
-188,992
-22% -$12.4M 0.35% 74
2014
Q2 		$53.5M Buy
859,296
+218,447
+34% +$13.2M 0.37% 81
2014
Q1 		$43.7M Buy
640,849
+232,959
+57% +$17.2M 0.29% 93
2013
Q4 		$28.7M Buy
407,890
+26,047
+7% +$1.77M 0.2% 131
2013
Q3 		$27.6M Sell
381,843
-338,212
-47% -$22.5M 0.2% 133
2013
Q2 		$40.1M Buy
+720,055
New +$44.9M 0.32% 86

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Columbus Circle Investors's BMRN Position: Q4 2017 in Review

Columbus Circle Investors sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2017, closing a stake of 84,232 shares — an estimated $7.84M sold.

Columbus Circle Investors first reported a position in BMRN in Q2 2013 and held it in 18 quarters. The position peaked at $53.5M in Q2 2014. 438 funds tracked by Wall St. Rank hold BMRN as of Q4 2017.

  • Columbus Circle Investors reported no remaining BioMarin Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 84,232 BioMarin Pharmaceuticals shares in Q4 2017, an estimated $7.84M.
  • Columbus Circle Investors first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Columbus Circle Investors's BioMarin Pharmaceuticals position peaked at $53.5M in Q2 2014.
  • 438 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.